|Articles|November 26, 2008
Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery
x
Advertisement
Please click
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
FLORetina 2025: Artificial intelligence at the frontlines of ROP care
2
FLORetina 2025: Port delivery system shows reliable 6-month durability and sustained efficacy in neovascular AMD for up to 7 years
3
How Digital Workflow Boosted my Confidence and Elevated Premium Patient Rates in Cataract Surgery
4
FLORetina 2025: Weight and PMA drive foveal maturation in preterm infants
5











































